Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Conditions
/ Fed
Fed
24 registered clinical trials studyying Fed —
1 currently recruiting
.
Status
Trial
Sponsor
Phase
Not Yet Recruiting
The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Health
NCT07396844
LG Chem
Phase 1
Unknown
Development of the Leeds Food Preference Questionnaire in Spanish
NCT05837572
Universidad de Granada
N/A
Completed
Comparative Bioavailability Study of TAH3311 5 mg Oral Dissolving Film vs ELIQUIS® 5 mg Tablet in Healthy Volu
NCT05995119
TAHO Pharmaceuticals Ltd.
EARLY_Phase 1
Completed
Use of Breath Acetone aa a Marker of Energy Balance
NCT03390881
University of Lausanne
N/A
Completed
Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fed Conditions
NCT01884909
IPCA Laboratories Ltd.
Phase 1
Completed
Satiety Effects on the Neural Valuation of Food
NCT01721187
Duke-NUS Graduate Medical School
—
Completed
Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed Conditions
NCT01827878
IPCA Laboratories Ltd.
Phase 1
Completed
Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fed Condition
NCT01744873
IPCA Laboratories Ltd.
Phase 1
Completed
Bioequivalence Study of Lisinopril Tablets 40 mg Under Fed Condition
NCT01735344
IPCA Laboratories Ltd.
Phase 1
Completed
Bioequivalence Study of Risperidone Tablet 1 mg Under Fed Condition
NCT01618760
IPCA Laboratories Ltd.
Phase 1
Completed
Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fed Condition
NCT01735383
IPCA Laboratories Ltd.
Phase 1
Completed
Bioequivalence Study of Indomethacin Extended-Release Capsules 75 mg Under Fed Condition
NCT01722110
IPCA Laboratories Ltd.
Phase 1
Completed
Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fed Condition
NCT01618825
IPCA Laboratories Ltd.
Phase 1
Completed
Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fed Condition
NCT01567501
IPCA Laboratories Ltd.
Phase 1
Completed
Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed Study
NCT01503424
Dr. Reddy's Laboratories Limited
Phase 1
Completed
Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fed Condition
NCT01578265
IPCA Laboratories Ltd.
Phase 1
Completed
Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fed Condition
NCT01603186
IPCA Laboratories Ltd.
Phase 1
Completed
Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablets of Dr.Reddy's Laboratories Limited Under Non-Fast
NCT01283867
Dr. Reddy's Laboratories Limited
Phase 1
Completed
Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed Condi
NCT01505998
Dr. Reddy's Laboratories Limited
Phase 1
Completed
Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed Condition
NCT01503450
Dr. Reddy's Laboratories Limited
Phase 1
Completed
Bioavailability Study of Desloratadine 5 mg Tablet of Dr. Reddy's Under Fed Conditions
NCT01314352
Dr. Reddy's Laboratories Limited
Phase 1
Completed
Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Non-Fasting Conditions
NCT01372358
Dr. Reddy's Laboratories Limited
Phase 1
Completed
Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fed Con
NCT01283932
Dr. Reddy's Laboratories Limited
Phase 1
Completed
Galantamine Bioequivalence Study of Dr. Reddy's Under Fed Condition
NCT01372306
Dr. Reddy's Laboratories Limited
Phase 1